Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, India.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 19 06 2020
accepted: 07 05 2021
entrez: 8 7 2021
pubmed: 9 7 2021
medline: 29 10 2021
Statut: epublish

Résumé

Neonatal sepsis is a major cause of death in India, which needs hospital management but many families cannot access hospitals. The World Health Organization and the Government of India developed a guideline to manage possible serious bacterial infection (PSBI) when a referral is not feasible. We implemented this guideline to achieve high coverage of treatment of PSBI with low mortality. The implementation research study was conducted in over 50 villages of Palwal district, Haryana during August 2017-March 2019 and covered a population of 199143. Policy dialogue with central, state and district health authorities was held before initiation of the study. A baseline assessment of the barriers in the implementation of the PSBI intervention was conducted. The intervention was implemented in the program setting. The research team collected data throughout and also co-participated in the implementation of the intervention for the first six months to identify bottlenecks in the health system and at the community level. RE-AIM framework was utilized to document implementation strategies of PSBI management guideline. Implementation strategies by the district technical support unit (TSU) included: (i) empower mothers and families through social mobilization to improve care-seeking of sick young infants 0-59 days of age, (ii) build capacity through training and build confidence through technical support of health staff at primary health centers (PHC), community health centers (CHC) and sub-centers to manage young infants with PSBI signs and (iii) improve performance of accredited social health activists (ASHAs). A total of 370 young infants with signs of PSBI were identified and managed in 5270 live births. Treatment coverage was 70% assuming that 10% of live births would have PSBI within the first two months of life. Mothers identified 87.6% (324/370) of PSBI cases. PHCs and CHCs became functional and managed 150 (40%) sick young infants with PSBI. Twenty four young infants (7-59days) who had only fast breathing were treated with oral amoxicillin without a referral. Referral to a hospital was refused by 126 (84%); 119 had clinical severe infection (CSI), one 0-6 days old had fast breathing and six had critical illness (CI). Of 119 CSI cases managed on outpatient injection gentamicin and oral amoxicillin, 116 (96.7%) recovered, 55 (45.8%) received all seven gentamicin injections and only one died. All 7-59 day old infants with fast breathing recovered, 23 on outpatient oral amoxicillin treatment; and 19 (79%) received all doses. Of 65 infants managed at either district or tertiary hospital, two (3.1%) died, rest recovered. Private providers managed 155 (41.9%) PSBI cases, all except one recovered, but sub-classification and treatment were unknown. Sub-centers could not be activated to manage PSBI. The study demonstrated resolution of implementation bottlenecks with existing resources, activated PHCs and CHCs to manage CSI and fast breathers (7-59 day old) on an outpatient basis with low mortality when a referral was not feasible. TSU was instrumental in these achievements. We established the effectiveness of oral amoxicillin alone in 7-59 days old fast breathers and recommend a review of the current national policy.

Sections du résumé

BACKGROUND
Neonatal sepsis is a major cause of death in India, which needs hospital management but many families cannot access hospitals. The World Health Organization and the Government of India developed a guideline to manage possible serious bacterial infection (PSBI) when a referral is not feasible. We implemented this guideline to achieve high coverage of treatment of PSBI with low mortality.
METHODOLOGY
The implementation research study was conducted in over 50 villages of Palwal district, Haryana during August 2017-March 2019 and covered a population of 199143. Policy dialogue with central, state and district health authorities was held before initiation of the study. A baseline assessment of the barriers in the implementation of the PSBI intervention was conducted. The intervention was implemented in the program setting. The research team collected data throughout and also co-participated in the implementation of the intervention for the first six months to identify bottlenecks in the health system and at the community level. RE-AIM framework was utilized to document implementation strategies of PSBI management guideline. Implementation strategies by the district technical support unit (TSU) included: (i) empower mothers and families through social mobilization to improve care-seeking of sick young infants 0-59 days of age, (ii) build capacity through training and build confidence through technical support of health staff at primary health centers (PHC), community health centers (CHC) and sub-centers to manage young infants with PSBI signs and (iii) improve performance of accredited social health activists (ASHAs).
FINDINGS
A total of 370 young infants with signs of PSBI were identified and managed in 5270 live births. Treatment coverage was 70% assuming that 10% of live births would have PSBI within the first two months of life. Mothers identified 87.6% (324/370) of PSBI cases. PHCs and CHCs became functional and managed 150 (40%) sick young infants with PSBI. Twenty four young infants (7-59days) who had only fast breathing were treated with oral amoxicillin without a referral. Referral to a hospital was refused by 126 (84%); 119 had clinical severe infection (CSI), one 0-6 days old had fast breathing and six had critical illness (CI). Of 119 CSI cases managed on outpatient injection gentamicin and oral amoxicillin, 116 (96.7%) recovered, 55 (45.8%) received all seven gentamicin injections and only one died. All 7-59 day old infants with fast breathing recovered, 23 on outpatient oral amoxicillin treatment; and 19 (79%) received all doses. Of 65 infants managed at either district or tertiary hospital, two (3.1%) died, rest recovered. Private providers managed 155 (41.9%) PSBI cases, all except one recovered, but sub-classification and treatment were unknown. Sub-centers could not be activated to manage PSBI.
CONCLUSION
The study demonstrated resolution of implementation bottlenecks with existing resources, activated PHCs and CHCs to manage CSI and fast breathers (7-59 day old) on an outpatient basis with low mortality when a referral was not feasible. TSU was instrumental in these achievements. We established the effectiveness of oral amoxicillin alone in 7-59 days old fast breathers and recommend a review of the current national policy.

Identifiants

pubmed: 34234352
doi: 10.1371/journal.pone.0252700
pii: PONE-D-20-18867
pmc: PMC8279773
doi:

Substances chimiques

Anti-Bacterial Agents 0
Gentamicins 0
Amoxicillin 804826J2HU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0252700

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

The authors have declared that no competing interest exist. Rajiv Bahl and Yasir Bin Nisar are staff members of the World Health Organization. The expressed views and opinions do not necessarily express the policies of the World Health Organization.

Références

Indian J Community Med. 2016 Apr-Jun;41(2):108-19
pubmed: 27051085
Acta Paediatr. 2018 Dec;107 Suppl 471:80-88
pubmed: 30570793
PLoS Med. 2012;9(3):e1001183
pubmed: 22412355
Lancet Glob Health. 2017 Feb;5(2):e177-e185
pubmed: 27988146
Lancet Glob Health. 2015 May;3(5):e279-87
pubmed: 25841891
Lancet. 2015 May 2;385(9979):1758-1766
pubmed: 25842223
Lancet. 1996 Jun 22;347(9017):1774-5
pubmed: 8656942
Pneumonia (Nathan). 2016 Nov 24;8:21
pubmed: 28702300
Lancet. 1999 Dec 4;354(9194):1955-61
pubmed: 10622298
J Health Popul Nutr. 2015 Mar;33(1):137-45
pubmed: 25995730
PLoS One. 2010 Mar 24;5(3):e9696
pubmed: 20352087
Pediatr Infect Dis J. 2009 Apr;28(4):304-10
pubmed: 19289979
PLoS One. 2019 Dec 27;14(12):e0226831
pubmed: 31881071
PLoS One. 2020 Aug 24;15(8):e0236355
pubmed: 32833993
PLoS One. 2020 Apr 14;15(4):e0229248
pubmed: 32287262
J Perinatol. 2008 Dec;28 Suppl 2:S31-7
pubmed: 19057566
Rural Remote Health. 2005 Oct-Dec;5(4):459
pubmed: 16241856
PLoS One. 2020 Dec 22;15(12):e0243724
pubmed: 33351810
Lancet. 2015 May 2;385(9979):1767-1776
pubmed: 25842221
Indian J Pediatr. 2009 Jan;76(1):45-50
pubmed: 19391002
Lancet. 2010 Apr 3;375(9721):1182-92
pubmed: 20207411
Lancet. 2008 Jun 7;371(9628):1936-44
pubmed: 18539225
PLoS One. 2020 Jun 4;15(6):e0234212
pubmed: 32497092
Lancet. 2008 Sep 27;372(9644):1151-62
pubmed: 18926277
Pediatr Infect Dis J. 2012 Jul;31(7):667-72
pubmed: 22481421
Lancet. 2018 Jul 14;392(10142):145-159
pubmed: 30025808
PLoS One. 2020 Apr 14;15(4):e0231490
pubmed: 32287286
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
BMC Public Health. 2015 Sep 30;15:989
pubmed: 26419934
BMC Pediatr. 2013 Sep 10;13:140
pubmed: 24020392
J Glob Health. 2014 Dec;4(2):020410
pubmed: 25520800
PLoS One. 2020 May 11;15(5):e0232675
pubmed: 32392209
PLoS One. 2020 Mar 10;15(3):e0228718
pubmed: 32155155
Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S65-85, S86-8
pubmed: 19815201
BMC Public Health. 2016 Jul 25;16:632
pubmed: 27456223
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Trop Pediatr. 2005 Dec;51(6):366-76
pubmed: 15927948

Auteurs

Rupak Mukhopadhyay (R)

The INCLEN Trust International, New Delhi, India.

Narendra Kumar Arora (NK)

The INCLEN Trust International, New Delhi, India.

Pradeep Kumar Sharma (PK)

Department of Health, Government of Haryana, Palwal/Chandigarh, India.

Suresh Dalpath (S)

Department of Health, Government of Haryana, Palwal/Chandigarh, India.

Priya Limbu (P)

The INCLEN Trust International, New Delhi, India.

Geetanjali Kataria (G)

The INCLEN Trust International, New Delhi, India.

Rakesh Kumar Singh (RK)

The INCLEN Trust International, New Delhi, India.

Ramesh Poluru (R)

The INCLEN Trust International, New Delhi, India.

Yogesh Malik (Y)

Department of Health, Government of Haryana, Palwal/Chandigarh, India.

Ajay Khera (A)

Ministry of Health and Family Welfare, Government of India, New Delhi, India.

P K Prabhakar (PK)

Ministry of Health and Family Welfare, Government of India, New Delhi, India.

Saket Kumar (S)

Department of Health, Government of Haryana, Palwal/Chandigarh, India.

Rakesh Gupta (R)

Department of Health, Government of Haryana, Palwal/Chandigarh, India.

Harish Chellani (H)

Department of Pediatrics, Vardhaman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.

Kailash Chander Aggarwal (KC)

Department of Pediatrics, Vardhaman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.

Ratan Gupta (R)

Department of Pediatrics, Vardhaman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.

Sugandha Arya (S)

Department of Pediatrics, Vardhaman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.

Samira Aboubaker (S)

Retired World Health Organization Staff, Geneva, Switzerland.

Rajiv Bahl (R)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Yasir Bin Nisar (YB)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Shamim Ahmad Qazi (SA)

Retired World Health Organization Staff, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH